Back
Tarsus Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
71
TARS
Tarsus Pharmaceuticals
Last Price:
$54.22
Seasonality Move:
31.22%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARS is experiencing slight buying pressure.
Tarsus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.99 | Buy |
| 20-day SMA: | 44.76 | Buy |
| 50-day SMA: | 42.55 | Buy |
| 200-day SMA: | 47.04 | Buy |
| 8-day EMA: | 50.4 | Buy |
| 20-day EMA: | 46.46 | Buy |
| 50-day EMA: | 44.27 | Buy |
| 200-day EMA: | 43.42 | Buy |
Tarsus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.06 | Buy |
| Relative Strength Index (14 RSI): | 78.63 | Buy |
| Chaikin Money Flow: | 78600 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.47 - 48.81) | Buy |
| Bollinger Bands (100): | (40.62 - 48.84) | Buy |
Tarsus Pharmaceuticals Technical Analysis
| Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Tarsus Pharmaceuticals Stock
Is Tarsus Pharmaceuticals Stock a Buy?
-
Tarsus Pharmaceuticals share price is 54.21 while TARS 8-day simple moving average is 49.99, which is a Buy signal.
-
The stock price of TARS is 54.21 while Tarsus Pharmaceuticals 20-day SMA is 44.76, which makes it a Buy.
-
Tarsus Pharmaceuticals 50-day simple moving average is 42.55 while TARS share price is 54.21, making it a Buy technically.
-
TARS stock price is 54.21 and Tarsus Pharmaceuticals 200-day simple moving average is 47.04, creating a Buy signal.
TARS Technical Analysis vs Fundamental Analysis
Buy
71
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy or a Sell?
-
Tarsus Pharmaceuticals stock is rated a BuyThe current Tarsus Pharmaceuticals [TARS] share price is $54.21. The Score for TARS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Tarsus Pharmaceuticals Stock Info
Market Cap:
2.3B
Price in USD:
54.21
Share Volume:
873.8K
Tarsus Pharmaceuticals 52-Week Range
52-Week High:
57.28
52-Week Low:
24.95
Buy
71
Tarsus Pharmaceuticals (TARS)
is a Buy
Tarsus Pharmaceuticals Share Price Forecast
-
What is the Tarsus Pharmaceuticals stock price today?The Tarsus Pharmaceuticals stock price is 54.21 USD today.
-
Will TARS stock go up or go down?Tarsus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Tarsus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Tarsus Pharmaceuticals is not overvalued.
Is Tarsus Pharmaceuticals Stock a Buy?
-
Tarsus Pharmaceuticals share price is 54.21 while TARS 8-day exponential moving average is 50.40, which is a Buy signal.
-
The stock price of TARS is 54.21 while Tarsus Pharmaceuticals 20-day EMA is 46.46, which makes it a Buy.
-
Tarsus Pharmaceuticals 50-day exponential moving average is 44.27 while TARS share price is 54.21, making it a Buy technically.
-
TARS stock price is 54.21 and Tarsus Pharmaceuticals 200-day simple moving average is 43.42, creating a Buy signal.
Fundamental Analysis of Tarsus Pharmaceuticals
Is Tarsus Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.65 per share, an increase next quarter of $0.75 per share, an increase this year of $1.59 per share, and an increase next year of $1.53 per share.
Technical Analysis of Tarsus Pharmaceuticals
Should I short Tarsus Pharmaceuticals stock?
-
TARS Moving Average Covergence Divergence (MACD) indicator is 3.06, suggesting Tarsus Pharmaceuticals is a Buy
-
Tarsus Pharmaceuticals Relative Strength Index (RSI) is 78.63, which suggest Tarsus Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Tarsus Pharmaceuticals is (39.47 - 48.81), which suggest Tarsus Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Tarsus Pharmaceuticals is (40.62 - 48.84), which suggest Tarsus Pharmaceuticals is a Buy
* Tarsus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.